118
Participants
Start Date
February 23, 2018
Primary Completion Date
February 7, 2020
Study Completion Date
February 7, 2020
Inflectra
The study plans to recruit 300 subjects in the United States and Canada initiating or switching to treatment with INFLECTRA over an 8 month period. The decision to start INFLECTRA will be entirely a clinical decision made by the participating physician irrespective of this study.
Gastro Center of Maryland, Columbia
Suncoast Research Group, LLC, Miami
Paramount Medical Research & consulting, LLC, Middleburg Heights
Dayton Gastroenterology, Inc., Beavercreek
Indiana University Health Division of Gastroenterology/Hepatology, Indianapolis
Infusion Associates N.E., Grand Rapids
Trinity Health Center Medical Arts, Minot
Illinois Gastroenterology Group, Gurnee
San Diego Clinical Trials, San Diego
The Vancouver Clinic Research, Vancouver
Medical Research Center Of Connecticut, LLC, Hamden
Aspen Woods Clinic, Calgary
Brennan Walters Professional Corporation, Edmonton
Fraser Clinical Trials, New Westminster
Montreal IBD Center (CMIIM), Montreal
Lead Sponsor
Pfizer
INDUSTRY